Literature DB >> 18054434

Regulation of SULT2B1a (pregnenolone sulfotransferase) expression in rat C6 glioma cells: relevance of AMPA receptor-mediated NO signaling.

Atsushi Kohjitani1, Hirotoshi Fuda, Osamu Hanyu, Charles A Strott.   

Abstract

The neurosteroid pregnenolone sulfate (PREGS), which is synthesized in glial cells, plays a significant role in learning and memory performance. The aim of this study was to investigate the regulation of expression of the steroid sulfotransferase SULT2B1a, which catalyzes the conversion of pregnenolone to PREGS, using the rat C6 glioma cell line. Rat C6 glioma cells expressed the SULT2B1a isoform, which sulfonates pregnenolone, but, neither the SULT2B1b isoform, which catalyzes cholesterol, nor the prototypical steroid sulfotransferase SULT2A1 were expressed in these cells. Increasing concentrations of l-glutamic acid in the presence of cyclothiazide, which prevents AMPA receptor desensitization, attenuated SULT2B1a mRNA expression; however, neither NMDA nor kainic acid had a significant effect. Exposure to the synthetic glutamate analogue alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) in the presence of cyclothiazide also inhibited SULT2B1a expression. Attenuation of SULT2B1a expression by L-glutamic acid was reversed by the selective AMPA/kainate receptor antagonist 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX), and partially reversed by the specific neuronal nitric oxide synthase (NOS) inhibitor 7-nitroindazole (7-NI). Induction of inducible NOS by TNF-alpha in combination with lipopolysaccharide (LPS) dramatically attenuated SULT2B1a expression; this was partially reversed by the specific inducible NOS inhibitor N(6)-(1-iminoethyl)-L-lysine hydrochloride (L-NIL). Furthermore, exposure to exogenous NO donors inhibited SULT2B1a mRNA expression, and exposure to sodium nitroprusside, LPS/TNF-alpha and L-glutamic acid in combination with cyclothiazide increased the production of nitrite, a stable degradation product of NO. These findings suggest that expression of SULT2B1a, which catalyzes PREGS production, is inhibited by activation of excitatory amino acid receptors of the AMPA subtype, via facilitation of intracellular NO signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054434     DOI: 10.1016/j.neulet.2007.10.023

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation.

Authors:  Masahito Suiko; Katsuhisa Kurogi; Takuyu Hashiguchi; Yoichi Sakakibara; Ming-Cheh Liu
Journal:  Biosci Biotechnol Biochem       Date:  2016-09-21       Impact factor: 2.043

2.  On the role of genetic polymorphisms in the sulfation of cholesterol by human cytosolic sulphotransferase SULT2B1b.

Authors:  Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Ahsan F Bairam; Mohammed I Rasool; Katsuhisa Kurogi; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  J Biochem       Date:  2018-09-01       Impact factor: 3.387

3.  Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol.

Authors:  Ozlem Gursoy Calan; Pinar Akan; Aysenur Cataler; Cumhur Dogan; Semra Kocturk
Journal:  Neurochem Res       Date:  2016-03-26       Impact factor: 3.996

Review 4.  Pregnenolone sulfate as a modulator of synaptic plasticity.

Authors:  Conor C Smith; Terrell T Gibbs; David H Farb
Journal:  Psychopharmacology (Berl)       Date:  2014-07-06       Impact factor: 4.530

5.  Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum.

Authors:  Matthew T Whittaker; Terrell T Gibbs; David H Farb
Journal:  J Neurochem       Date:  2008-08-14       Impact factor: 5.372

6.  Nanomolar concentrations of pregnenolone sulfate enhance striatal dopamine overflow in vivo.

Authors:  G Sadri-Vakili; G C Janis; R C Pierce; T T Gibbs; D H Farb
Journal:  J Pharmacol Exp Ther       Date:  2008-09-04       Impact factor: 4.030

7.  The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Raquel Herrero-Labrador; Ricardo Martínez-Murillo; Manuel Merlos; José Miguel Vela; Javier Garzón
Journal:  Antioxid Redox Signal       Date:  2015-02-18       Impact factor: 8.401

8.  Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway.

Authors:  P Wong; Y Sze; C C R Chang; J Lee; X Zhang
Journal:  Transl Psychiatry       Date:  2015-03-17       Impact factor: 6.222

9.  Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.

Authors:  Melissa Runge-Morris; Thomas A Kocarek
Journal:  PPAR Res       Date:  2009-08-10       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.